Qaderi K, Shahmoradi A, Thyagarajan A, Sahu R
Mil Med Res. 2025; 12(1):10.
PMID: 40033370
PMC: 11877967.
DOI: 10.1186/s40779-025-00597-0.
Thyagarajan A, Travers J, Sahu R
Free Radic Biol Med. 2024; 228:62-67.
PMID: 39706499
PMC: 11788046.
DOI: 10.1016/j.freeradbiomed.2024.12.037.
Frommeyer T, Gilbert M, Brittain G, Wu T, Nguyen T, Rohan C
Front Immunol. 2022; 13:880850.
PMID: 35603177
PMC: 9120817.
DOI: 10.3389/fimmu.2022.880850.
Travers J, Rohan J, Sahu R
Front Endocrinol (Lausanne). 2021; 12:624132.
PMID: 33796070
PMC: 8008455.
DOI: 10.3389/fendo.2021.624132.
Gruber F, Marchetti-Deschmann M, Kremslehner C, Schosserer M
Front Endocrinol (Lausanne). 2021; 11:607076.
PMID: 33551998
PMC: 7859619.
DOI: 10.3389/fendo.2020.607076.
Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
Chauhan S, Thyagarajan A, Chen Y, Travers J, Sahu R
Int J Mol Sci. 2020; 21(22).
PMID: 33198218
PMC: 7696385.
DOI: 10.3390/ijms21228517.
Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor.
Liu L, Fahy K, Awoyemi A, Thapa P, Kelly L, Chen J
J Immunol. 2020; 205(1):193-201.
PMID: 32434939
PMC: 7342023.
DOI: 10.4049/jimmunol.1901393.
Platelet-Activating Factor as an Effector for Environmental Stressors.
Travers J
Handb Exp Pharmacol. 2019; 259:185-203.
PMID: 31087194
PMC: 7112171.
DOI: 10.1007/164_2019_218.
Acute Ethanol Exposure Augments Low-Dose UVB-Mediated Systemic Immunosuppression via Enhanced Production of Platelet-Activating Factor Receptor Agonists.
Travers J, Weyerbacher J, Ocana J, Borchers C, Rapp C, Sahu R
J Invest Dermatol. 2019; 139(7):1619-1622.
PMID: 30682347
PMC: 6996287.
DOI: 10.1016/j.jid.2018.11.034.
A novel role for NUPR1 in the keratinocyte stress response to UV oxidized phospholipids.
Narzt M, Nagelreiter I, Oskolkova O, Bochkov V, Latreille J, Fedorova M
Redox Biol. 2018; 20:467-482.
PMID: 30466060
PMC: 6243031.
DOI: 10.1016/j.redox.2018.11.006.
Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy.
da Silva Junior I, Andrade L, Jancar S, Chammas R
Clinics (Sao Paulo). 2018; 73(suppl 1):e792s.
PMID: 30328954
PMC: 6157068.
DOI: 10.6061/clinics/2018/e792s.
Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.
Romer E, Thyagarajan A, Krishnamurthy S, Rapp C, Liu L, Fahy K
Int J Mol Sci. 2018; 19(10).
PMID: 30314274
PMC: 6212876.
DOI: 10.3390/ijms19103109.
Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.
Konger R, Derr-Yellin E, Travers J, Ocana J, Sahu R
Oncotarget. 2017; 8(58):98184-98199.
PMID: 29228682
PMC: 5716722.
DOI: 10.18632/oncotarget.21002.
Feeding a Mixture of Choline Forms during Lactation Improves Offspring Growth and Maternal Lymphocyte Response to Ex Vivo Immune Challenges.
Lewis E, Richard C, Goruk S, Wadge E, Curtis J, Jacobs R
Nutrients. 2017; 9(7).
PMID: 28686201
PMC: 5537828.
DOI: 10.3390/nu9070713.
Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization.
Thyagarajan A, Sahu R
Integr Cancer Ther. 2017; 17(2):210-216.
PMID: 28627256
PMC: 6041931.
DOI: 10.1177/1534735416681639.
Platelet-Activating Factor-Receptor and Tumor Immunity.
Sahu R, Konger R, Travers J
JSM Cell Dev Biol. 2016; 2(1).
PMID: 27239560
PMC: 4880409.
Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
Damiani E, Ullrich S
Prog Lipid Res. 2016; 63:14-27.
PMID: 27073146
PMC: 4975990.
DOI: 10.1016/j.plipres.2016.03.004.
Radiation therapy generates platelet-activating factor agonists.
Sahu R, Harrison K, Weyerbacher J, Murphy R, Konger R, Garrett J
Oncotarget. 2016; 7(15):20788-800.
PMID: 26959112
PMC: 4991492.
DOI: 10.18632/oncotarget.7878.
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
Sahu R, Ferracini M, Travers J
Mediators Inflamm. 2015; 2015:820543.
PMID: 25922565
PMC: 4398925.
DOI: 10.1155/2015/820543.
Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.
Sahu R, Rezania S, Ocana J, DaSilva-Arnold S, Bradish J, Richey J
PLoS One. 2014; 9(11):e111608.
PMID: 25375862
PMC: 4222871.
DOI: 10.1371/journal.pone.0111608.